Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sapropterin for Neuropsychiatric Symptoms in PKU
NCT01114737Phase 3Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Aug 2010
- Primary completion
- Mar 2013
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of sapropterin in phenylketonuria (PKU), sponsored by BioMarin Pharmaceutical. Started Aug 2010; status: completed.
02
Drugs
sapropterin
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT01114737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01114737.